HomeDiscussions$CAPR Q4 '24 Earnings Results & Recap
Capricor reported Q4 2024 EPS of -$0.16 (vs -$0.17 estimated) and revenue of $11.13M (vs. $3.52M estimated). The FDA accepted the BLA for priority review, setting a PDUFA date of August 31, 2025.
Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
$CAPR Q4 '24 Earnings Results & Recap
Capricor reported Q4 2024 EPS of -$0.16 (vs -$0.17 estimated) and revenue of $11.13M (vs. $3.52M estimated). The FDA accepted the BLA for priority review, setting a PDUFA date of August 31, 2025.